Not applicableUnknownNCT00898092What this trial is testingGenetics Study of Tissue Collected From Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 735
Early research (Phase 1)Study completedNCT00003395What this trial is testingArsenic Trioxide in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00454480What this trial is testingCombination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes The University of New South Wales 2,000
Not applicableStudy completedNCT00844441What this trial is testingEarly Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 96
Early research (Phase 1)Study completedNCT00093483What this trial is testingArsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Roswell Park Cancer Institute 61
Large-scale testing (Phase 3)Study completedNCT00372593What this trial is testingCombination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 1,070
Early research (Phase 1)Study completedNCT00101153What this trial is testingTipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia University Health Network, Toronto 24
Early research (Phase 1)Study completedNCT00357305What this trial is testingVorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+31 more National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT01235572What this trial is testingEarly Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive ChemotherapyWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+14 more Fred Hutchinson Cancer Center 200
Early research (Phase 1)Study completedNCT00131989What this trial is testingSorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00027872What this trial is testingTipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+18 more National Cancer Institute (NCI) 125
Early research (Phase 1)Ended earlyNCT01260714What this trial is testingAzacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+18 more National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT00352365What this trial is testingLenalidomide in Treating Older Patients With Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Ended earlyNCT00096148What this trial is testingIdarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+21 more National Cancer Institute (NCI) 120
Early research (Phase 1)Ended earlyNCT00103272What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic CancerWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT00217646What this trial is testingSorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia+21 more National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)UnknownNCT00651261What this trial is testingDaunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 717
Not applicableStudy completedNCT01385150What this trial is testingBiomarkers in Blood Samples From Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Eastern Cooperative Oncology Group 220
Not applicableStudy completedNCT01360125What this trial is testingS0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based ChemotherapyWho this might be right forLeukemia SWOG Cancer Research Network 310
Testing effectiveness (Phase 2)Study completedNCT00023777What this trial is testingS0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 71